Effectiveness of Interventions to Teach Respiratory Inhaler Technique (E-TRaIN): Complete Statistical Analysis

1. Trial at a Glance

This page covers the registry results for Effectiveness of Interventions to Teach Respiratory Inhaler Technique (E-TRaIN) (NCT01426581), a randomized na study. The primary outcome is Percentage of Participants With MDI Misuse From Baseline to 30 Days Post-Discharge.

2. Clinical Question

3. Trial Design

NCT01426581, titled Effectiveness of Interventions to Teach Respiratory Inhaler Technique (E-TRaIN), is recorded as a completed, randomized, single-masked, parallel-group study sponsored by the University of Chicago. The registry lists enrollment of 120 participants and conditions of asthma and chronic obstructive pulmonary disease (COPD). The phase is recorded as not applicable. The listed study start is 2011-08, and primary completion is 2012-12.

Participants were assigned to one of two behavioral educational interventions. Educational Intervention A is described as Teach to Goal, and Educational Intervention B as Brief Intervention. TTG uses instruction and teach-back with repeated learning and assessment; BI uses verbal and written instruction. The registry identifies the study as single-masked but does not report which people were masked or how masking was maintained. Allocation details beyond the randomized designation are not reported in the registry record.

The study’s stated purpose was to evaluate the relative effectiveness of these teaching approaches during hospitalization and to assess durability after discharge. The primary outcome concerns MDI misuse from baseline to 30 days post-discharge. The brief description also discusses MDI and Diskus® technique separately, but the record does not provide a primary result by device. It lists secondary outcomes related to health literacy, self-efficacy, symptom control, and acute-care events. The registry record does not report the detailed study protocol, the randomization procedure, the planned analysis population, or the handling of participants who did not complete follow-up.

4. Participant Flow and Accounting

The registry reports how participants moved through each stage of the study. All counts below are exactly as posted; missing counts are not inferred from other stages.

Overall Study

5. Baseline Characteristics

The table reproduces the baseline characteristics posted in the registry, which describe the participants analysed at baseline and help show whether the randomized groups were comparable.

6. Primary Endpoint

The registry lists the primary outcome as Percentage of Participants With MDI Misuse From Baseline to 30 Days Post-Discharge, measured over 1 month.

The primary endpoint is the percentage of participants with MDI misuse from baseline to 30 days post-discharge. It is intended to capture whether participants retain instruction in correct metered-dose inhaler technique after leaving the hospital. Comparing the two educational approaches on this endpoint would address the study’s stated question about post-discharge retention, rather than only whether instruction was delivered during hospitalization.

An endpoint based on misuse requires a definition of what counts as misuse and a consistent assessment procedure. Those details are not reported in the registry record. The record also does not report the observed percentages, the number of participants assessed at each time point, or an estimate comparing the intervention groups. Its primary-outcome listing indicates multiple categories or time points, so the outcome was not reduced to one comparison in the registered results. As a result, the endpoint’s intended meaning can be described, but its observed direction, magnitude, and precision cannot be established from the registry record.

7. Why No Re-analysis Is Shown

8. Statistical Interpretation

9. Statistical Methods Explained

The design and outcome description support a limited explanation of the statistical questions, but not a reconstruction of the analysis. The registry record identifies randomization and a parallel comparison of Teach-to-Goal with Brief Intervention. It does not report the statistical analysis plan, so the precise methods used or intended cannot be established from this record.

What does randomization contribute?

In general, randomization assigns participants to study groups using a chance-based process. Its purpose is to reduce systematic differences between groups at the time of assignment, including differences that investigators may not have measured. Randomization does not guarantee that groups will be identical, particularly in a study of limited size. It also does not, by itself, address missing follow-up outcomes, departures from assigned intervention, or differences in how outcomes are measured. The registry record does not describe the sequence-generation or allocation-concealment procedures for this study.

The parallel-group designation means that participants were assigned to one educational intervention group rather than the other, as opposed to each participant receiving both interventions in sequence. The record describes the two interventions, but it does not provide enough detail to determine whether additional components of care were standardized or how adherence to the teaching approaches was assessed.

What does the primary outcome require?

The registered primary outcome is a percentage of participants with MDI misuse, with the stated comparison spanning baseline to 30 days post-discharge. For a percentage comparison, the analysis ordinarily depends on a clearly defined misuse criterion, a denominator for each group and time point, and a specified approach to handling participants without an assessment. These are general considerations, not reported details of the E-TRaIN analysis. The registry record does not define the misuse threshold or provide outcome counts, denominators, or an analysis method.

Because the primary-outcome entry refers to several categories or time points, selecting a single summary could conceal distinctions in timing or outcome classification. A statistical analysis needs to specify which contrast addresses the primary question and how the observations contribute to that contrast. The record does not reduce the outcome to one comparison and does not explain the choice of categories or time points. It therefore does not support a numerical interpretation of the primary endpoint.

How should uncertainty be assessed?

In general, an estimated difference between groups is more informative when presented with a measure of uncertainty, such as a confidence interval. The estimate describes the observed contrast under the analysis; the interval communicates how much uncertainty remains around it. A p-value addresses compatibility with a specified null hypothesis under the statistical model, but is not a measure of effect size or clinical importance. Neither a primary estimate, confidence interval, nor p-value is reported in the registry record, so no inference about the magnitude or statistical uncertainty of the group contrast can be made.

The outcome is described as a percentage, but the registry’s outcome classification does not itself reveal which statistical model was used. General options for binary outcomes include methods based on proportions or regression models, with their assumptions depending on the exact estimand and data structure. The statistical method, any covariate adjustment, and any checks of model assumptions are not reported in the registry record. It would be inappropriate to infer a particular method from the outcome label alone.

What do the planning assumptions mean?

The registry description of a planning illustration states that it uses a two-sided significance level of 0.05, equal allocation between groups, and a normal approximation, with the effect to detect expressed as a fraction of the observed effect. It also distinguishes participant counts per arm for non-time-to-event outcomes from total event counts for time-to-event outcomes. These are planning assumptions, not evidence that the trial had a particular achieved power or that its protocol used those assumptions. The illustration is explicitly separate from the trial’s own design. The numerical planning counts and the trial’s sample-size justification are not reported in the registry record.

In general, a sample-size calculation describes the information a study might need under stated assumptions. It is not a measure of the probability that a completed study’s finding is correct, and it cannot replace a reported estimate with uncertainty. Since the primary result is not reported, the planning illustration cannot be used to infer the observed effect or the precision of an E-TRaIN comparison.

Over-dispersion is a general concern when observed variation exceeds what a chosen statistical model assumes. If present, it can make standard errors too small under a model that fails to account for the extra variability. The registry record does not report an over-dispersion assessment, and the available primary-outcome description is insufficient to determine whether that issue arose. This is a general methodological consideration, not a finding about this trial.

10. Multiplicity, Missing Data and Analysis Populations

The study record lists a primary outcome involving MDI misuse from baseline to 30 days post-discharge, while its brief description also discusses retention for MDI and Diskus® devices separately. It lists secondary outcomes related to health literacy and acute-care events, self-efficacy, and symptom control. Considering multiple outcomes, devices, time points, or categories can create multiplicity: the more contrasts examined, the greater the chance that at least one appears notable by chance. In general, a statistical plan may address this by identifying a primary contrast in advance or by using an adjustment. The registry record does not report a multiplicity strategy, a hierarchy among comparisons, or a detailed analysis plan.

The registry’s primary-outcome entry indicates multiple categories or time points and is not reduced to one comparison. No outcome estimates or analyses are reported. Therefore, the record does not permit assessment of how multiple comparisons were handled or whether any reported contrast was selected from a larger set of analyses.

Missing data can also affect interpretation. Participants may lack a follow-up assessment for many reasons, and the consequences depend on how missingness relates to group assignment and outcome status. In general, an analysis should clarify how many participants were assessed, how many were missing, and what assumptions or methods were used to address missing observations. The record does not report follow-up denominators, missing-outcome counts, imputation, or sensitivity analyses.

The analysis populations are also not described. In general, an intention-to-treat analysis retains participants in their randomized groups, while other analysis populations may apply additional eligibility or adherence criteria. The registry record does not state which population was used for the primary outcome. These omissions limit reproducibility and make it impossible to judge whether the registered question and the analyzed population align.

11. Safety Results

The registry reports serious adverse events as affected participants divided by participants at risk.

Other (non-serious) adverse events

Participants with at least one non-serious event at or above the registry's 0% reporting threshold.

The safety entries list 62 participants at risk in Educational Intervention A and 58 in Educational Intervention B. The record lists 0 serious adverse events and 0 other adverse events for each group. These are the counts recorded in the registry safety fields; they do not constitute a comparison of the educational approaches’ effects on safety.

The death entries are null, so deaths are not reported in the registry record. A null entry should not be interpreted as a confirmed count of zero. The record also does not provide event definitions, collection procedures, follow-up completeness, or detail about whether the entries represent all events or only events meeting specified reporting criteria. It does not provide event-level descriptions or a statistical safety analysis.

These figures concern the adverse-event fields, not the primary inhaler-misuse outcome. In general, a lack of recorded events in a registry entry does not establish that no events occurred outside the reported categories or observation period. Nor does it establish equivalence between groups. The safety information is therefore best read as the counts recorded for the listed groups, alongside the limitations of the registry reporting.

12. What the Result Does, and Does Not, Mean

The record identifies a clinically focused educational question: whether repeated instruction and teach-back, compared with verbal and written instruction, is associated with retention of correct MDI technique after hospital discharge. It gives the primary outcome’s intended timing and lists secondary outcomes that concern self-efficacy, symptom control, health literacy, and acute-care events. This information clarifies what the study set out to examine.

It does not establish what the study found. The registry record does not report a primary outcome estimate or a single analyzed comparison. It provides no group-specific MDI misuse percentages, uncertainty intervals, or test results. Consequently, it cannot show the direction or size of a difference, whether estimates were precise, or whether the two educational approaches had similar outcomes.

That distinction matters because absence of a reported comparison is not a null finding. It is also not evidence that participants did or did not retain inhaler technique. The outcome’s multiple categories or time points were not reduced to one comparison in the registry entry, and the record does not explain how those elements were analyzed. The posted information therefore supports a description of the research question and design, not a conclusion about comparative effectiveness.

The study enrolled 120 participants and is listed as completed, but enrollment alone does not show how many participants contributed to the primary outcome at follow-up. The registry record does not report the assessed sample, missing data, analysis population, or methods used. Those details are needed to understand how much information the outcome provides and how broadly any analysis might apply.

In general, statistical evidence should be interpreted through an estimate, its uncertainty, the design, and the assumptions of the analysis. Here, the outcome estimate and analysis are not reported in the registry record. Any stronger conclusion about the intervention comparison would go beyond the available registry information.

13. Why This Trial Matters Statistically

E-TRaIN illustrates an important distinction between registering a research question and reporting an analyzable result. The record identifies randomization, two educational approaches, a defined follow-up window, and a primary outcome focused on MDI misuse. Those elements make the intended comparison understandable. Yet without a reported contrast and its uncertainty, readers cannot judge the size, direction, or precision of the result.

The endpoint also raises a useful statistical issue: an outcome described across multiple categories or time points may not correspond to one simple comparison. A transparent analysis needs to clarify which contrast answers the main question and how the different observations are handled. The registry record does not report that clarification. This limits independent interpretation even though the broad question and outcome label are present.

Study design details matter alongside statistical results. Randomization can support a fair comparison, but interpretation also depends on outcome assessment, follow-up completeness, analysis population, and a clearly specified method. The registry record does not report these details. Its safety entries likewise need to be read as recorded counts rather than as a complete comparative safety analysis.

The planning assumptions described in the record serve a different purpose from outcome evidence. General sample-size planning depends on assumptions about the effect and analysis; it cannot substitute for a completed estimate or provide observed power. Because the primary result is not reported, readers cannot connect a planning illustration to the precision of the actual comparison.

For biostatisticians and clinical researchers, the case underscores the value of reporting outcome definitions, denominators, missingness, analysis populations, methods, and estimates with uncertainty. Without those elements, the registry record can establish what was intended and how the trial was broadly organized, but it cannot support a quantitative interpretation of the primary research question.

14. Limitations

• The posted summary statistics are the only data these results rest on; patient-level data, full protocols and statistical analysis plans are not available.
• Recalculated results are simple, unadjusted calculations from posted summaries. They do not replace the sponsor's prespecified analysis.

A central limitation of the registry information is that it does not report an analyzed primary outcome result. The primary entry describes MDI misuse across baseline and 30 days post-discharge but indicates several categories or time points and is not reduced to one comparison. The registry record does not provide the category definitions, outcome counts, denominators, or group-specific percentages. This prevents assessment of the endpoint’s observed pattern.

The record also lacks the details needed to assess the analysis. The statistical plan, primary contrast, analysis population, covariate adjustment, missing-data handling, and multiplicity approach are not reported in the registry record. Although the study is identified as single-masked, the masked party and procedures are not stated. The method of random sequence generation and allocation concealment is also not reported.

Enrollment is recorded as 120, but the number contributing primary-outcome data at follow-up is not reported. The registry lists secondary outcome topics without reporting their results. Baseline characteristics, intervention fidelity, and the operational definition of MDI misuse are not reported in the registry record. These gaps limit evaluation of comparability, outcome measurement, follow-up, and the relevance of any eventual analysis.

The safety fields list zero serious and zero other adverse events for the two groups, while death entries are null. The record does not describe the completeness or scope of safety ascertainment. Those entries therefore cannot resolve broader questions about safety monitoring or comparative risk.

15. Related Tutorials

16. Related Statistical Calculators

17. Sources

• ClinicalTrials.gov: Effectiveness of Interventions to Teach Respiratory Inhaler Technique (E-TRaIN) — NCT01426581.
• Registry record last updated 2019-11-19; status last verified 2019-10.
• Results first posted 2019-10-29.
• Data retrieved from ClinicalTrials.gov on 2026-11-09.
• Group sizes, means, event counts and sponsor-reported p-values are reproduced as posted. Effect estimates, confidence intervals and p-values not attributed to the sponsor are independently calculated from the posted summary statistics.

18. Record Summary

NCT01426581, Effectiveness of Interventions to Teach Respiratory Inhaler Technique (E-TRaIN), is a completed randomized, single-masked, parallel-group study sponsored by the University of Chicago. The registry lists enrollment of 120 and conditions of asthma and chronic obstructive pulmonary disease (COPD). The study compared hospital-based Teach-to-Goal education, using instruction and teach-back, with Brief Intervention, using verbal and written instruction.

The primary outcome concerns the percentage of participants with MDI misuse from baseline to 30 days post-discharge. The registry record lists secondary outcomes involving health literacy, self-efficacy, symptom control, and acute-care events. It does not report a reduced primary comparison or an analyzed result. The safety entries record 0 serious and 0 other adverse events in each group; death counts are not reported in the registry record.

The listed study start is 2011-08, and primary completion is 2012-12. The analysis plan, primary estimate, uncertainty interval, follow-up denominators, and missing-data methods are not reported in the registry record.